Skip NavigationSkip to Content
Loading

What’s New at the NCL

Recent Publications

Common pitfalls in nanotechnology: lessons learned from NCI’s Nanotechnology Characterization Laboratory.
Crist, R. M.; Grossman, J. H.; Patri, A. K.; Stern, S. T., Dobrovolskaia, M. A., Adiseshaiah, P. P., Clogston, J. D.; McNeil, S. E.
Integrative Biology (Camb). 2012. [Epub ahead of print]
PMID: 22772974

Autophagy and lysosomal dysfunction as emerging mechanisms of nanomaterial toxicity.
Stern, S. T., Adiseshaiah, P. P., Crist, R. M.
Particle and Fibre Toxicology 2012, 9:20.
PMID: 22697169

Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro.
Dobrovolskaia, M. A.; Patri, A. K., Simak, J., Hall, J. B., Semberova, J.; De Paoli Lacerda, S. H.; McNeil, S. E.
Molecular Pharmaceutics 2012, 9(3), 382-393.
PMID: 22026635.

Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge.
Dobrovolskaia, M. A.; Patri, A. K.; Potter, T. M.; Rodriguez, J. C.; Hall, J. B.; McNeil, S. E.
Nanomedicine (Lond). 2012, 7(2), 245-256.
PMID: 21957862.

Sterilization of silver nanoparticles using standard gamma irradiation procedure affects particle integrity and biocompatibility.
Zheng, J.; Clogston, J. D.; Patri, A. K.; Dobrovolskaia, M. A.; McNeil, S. E.
Journal of Nanomedicine and Nanotechnology, November 2011 [Epub ahead of print].
DOI: 10.4172/2157-7439.S5-001

Nanoparticle size and surface charge determine effects of PAMAM dendrimers on human platelets in vitro.
Dobrovolskaia, M. A.; Patri, A. K., Simak, J., Hall, J. B., Semberova, J.; De Paoli Lacerda, S. H.; McNeil, S. E.
Molecular Pharmaceutics 2011 Nov 10. [Epub ahead of print]
PMID: 22026635.

Dendrimer-induced leukocyte procoagulant activity depends on particle size and surface charge.
Dobrovolskaia, M. A.; Patri, A. K.; Potter, T. M.; Rodriguez, J. C.; Hall, J. B.; McNeil, S. E.
Nanomedicine (Lond). 2011 Sep 30. [Epub ahead of print]
PMID: 21957862.

Design and self-assembly of siRNA-functionalized RNA nanoparticles for use in automated nanomedicine.
Afonin ,K. A.; Grabow, W. W.; Walker, F. M.; Bindewald, E.; Dobrovolskaia, M. A.; Shapiro, B. A.; Jaeger, L.
Nature Protocols, 2011, 6(12), 2022-2034.
PMID: 22134126.

Preclinical efficacy and toxicity testing of engineered nanomaterials inNanomedicine – Basic and Clinical Applications in Diagnostics and Therapy.
Grossman, J. H.; McNeil, S. E.
Else Kroner-Fresenius Symposia, Karger Press; 2011, vol. 2, p71-79, Christoph Alexiou, editor.
ISBN: 978-3-8055-9818-7.

Macrophage scavenger receptor A mediates the uptake of gold colloids by macrophages in vitro.
Franca, A.; Aggarwal, P.; Barsov, E.; Kozlov, S.; Dobrovolskaia, M. A.; Gonzalez-Fernandez, A.
Nanomedicine (Lond.), 2011, 6(7), 1175-1188.
PMID: 21675859.

Newkome-type dendron stabilized gold nanoparticles: Synthesis, reactivity, and stability.
Cho, T. J.; Zangmeister, R. A.; Maccuspie, R. I.; Patri, A. K.; Hackley, V. A.
Chemistry of Materials, 2011, 23(10), 2665-2676.
PMID: 21686078.

Interlaboratory comparison of size and surface charge measurements on nanoparticles prior to biological impact assessment.
Roebben, G.; Ramirez-Garcia, S.; Hackley, V. A., Roesslein, M.; Klaessig, F.; Kestens, V.; Lynch, I.; Garner, C. M.; Rawle, A.; Elder, A.; Colvin, V. L.; Kreyling, W.; Krug, H. F.; Lewicka, Z. A.; McNeil, S. E.; Nel, A.; Patri, A. K.; Wick, P.; Wiesner, M.; Xia, T.; Oberdorster, G.; Dawson, K. A.
Journal of Nanoparticle Research, 2011, 13(7), 2675-2687.

 

Page last updated March 7, 2013 @ 7:32 am